Biochemical Pharmacology
Combinatorial strategies to potentiate the efficacy of HDAC inhibitors in fusion-positive sarcomas
Publication date: April 2022Source: Biochemical Pharmacology, Volume 198Author(s): Cinzia Lanzi, Giuliana Cassinelli
Biochemical Pharmacology
Glucocorticoids and natural killer cells: A suppressive relationship
Publication date: April 2022Source: Biochemical Pharmacology, Volume 198Author(s): Isabella Muscari, Alessandra Fierabracci, Sabrina Adorisio, Marina Moretti, Lorenza Cannarile, Vu Thi Minh Hong, Emira Ayroldi, Domenico V. Delfino
Biochemical Pharmacology
Second messenger 2′3′-cyclic GMP–AMP (2′3′-cGAMP): Synthesis, transmission, and degradation
Publication date: April 2022Source: Biochemical Pharmacology, Volume 198Author(s): Mincun Su, Jianpei Zheng, Linchuan Gan, Yuxiang Zhao, Yajuan Fu, Qi Chen
Biochemical Pharmacology
Sex, estrous cycle, and hormone regulation of CYP2D in the brain alters oxycodone metabolism and analgesia
Publication date: April 2022Source: Biochemical Pharmacology, Volume 198Author(s): Nicole Arguelles, Janielle Richards, Ahmed A. El-Sherbeni, Sharon Miksys, Rachel F. Tyndale
Biochemical Pharmacology
Biogenesis and function of extracellular vesicles in pathophysiological processes of skeletal muscle atrophy
Publication date: April 2022Source: Biochemical Pharmacology, Volume 198Author(s): Wei Wang, Ming Li, Zehao Chen, Lai Xu, Mengyuan Chang, Kexin Wang, Chunyan Deng, Yun Gu, Songlin Zhou, Yuntian Shen, Feng Tao, Hualin Sun
Biochemical Pharmacology
Is (R)-ketamine a potential therapeutic agent for treatment-resistant depression with less detrimental side effects? A review of molecular mechanisms underlying ketamine and its enantiomers
Publication date: April 2022Source: Biochemical Pharmacology, Volume 198Author(s): Ellen Scotton, Bárbara Antqueviezc, Mailton França de Vasconcelos, Giovana Dalpiaz, Luiza Paul Géa, Jéferson Ferraz Goularte, Rafael Colombo, Adriane Ribeiro Rosa
Biochemical Pharmacology
Post-translational modification of MALT1 and its role in B cell- and T cell-related diseases
Publication date: April 2022Source: Biochemical Pharmacology, Volume 198Author(s): Yi-Yue Zhang, Jun Peng, Xiu-Ju Luo
Biochemical Pharmacology
Animal models of acute lymphoblastic leukemia: Recapitulating the human disease to evaluate drug efficacy and discover therapeutic targets
Publication date: April 2022Source: Biochemical Pharmacology, Volume 198Author(s): Qianling Xin, Zhaoying Chen, Wei Wei, Yujing Wu
Biochemical Pharmacology
Therapeutic strategies for tauopathies and drug repurposing as a potential approach
Publication date: April 2022Source: Biochemical Pharmacology, Volume 198Author(s): Majedul Islam, Fengyun Shen, Deepika Regmi, Deguo Du
Biochemical Pharmacology
Nigericin exerts anticancer effects through inhibition of the SRC/STAT3/BCL-2 in osteosarcoma
Publication date: April 2022Source: Biochemical Pharmacology, Volume 198Author(s): Zhiqiang Yang, Jiangtao Xie, Jiayu Fang, Minchao Lv, Min Yang, Zhouming Deng, Yuanlong Xie, Lin Cai